Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Grant/Award of 17,249 AKTX shares, $136.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Akari Therapeutics Plc (AKTX) | Grant/Award | 17,249 | $136.2K |
| Jun 12, 2026 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 70,000 | n/a |
| Dec 19, 2025 | Akari Therapeutics Plc (AKTX) | Purchase | 618,658 | n/a |
| Jun 10, 2025 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 30,000 | n/a |
| Mar 24, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 175,000 | n/a |
| Mar 10, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 892,857 | $1000.0K |
| Jun 18, 2024 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 26,764 | n/a |
| Jun 8, 2023 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 14,000 | n/a |
| Jun 21, 2022 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 15,000 | n/a |
| Jul 1, 2021 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 13,286 | n/a |